Literature DB >> 16106081

Natural killer cell immune responses.

Wayne M Yokoyama1.   

Abstract

Natural killer (NK) cells play a vital role in innate immune responses to infection; they express activation receptors that recognize virus-infected cells. Highly related to receptors recognizing tumor cells, the activation receptors trigger cytotoxicity and cytokine production. NK cells also express inhibitory receptors for major histocompatibility complex (MHC) class I molecules that block the action of the activation receptors. Although many ligands for NK cell receptors have MHC class I folds, recent studies also indicate ligands resembling the NK cell receptors themselves. A combination of immunologic, genetic, biophysical, and in vivo approaches is being employed to understand fully how these receptors contribute to NK cell activities in innate immunity to pathogens and tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16106081     DOI: 10.1385/IR:32:1-3:317

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  71 in total

1.  Cloning of Clr, a new family of lectin-like genes localized between mouse Nkrp1a and Cd69.

Authors:  B Plougastel; C Dubbelde; W M Yokoyama
Journal:  Immunogenetics       Date:  2001-04       Impact factor: 2.846

Review 2.  Immune functions encoded by the natural killer gene complex.

Authors:  Wayne M Yokoyama; Beatrice F M Plougastel
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

3.  Chromosomal location of the Ly-49 (A1, YE1/48) multigene family. Genetic association with the NK 1.1 antigen.

Authors:  W M Yokoyama; P J Kehn; D I Cohen; E M Shevach
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

Review 4.  Killer cell inhibitory receptors: diversity, specificity, and function.

Authors:  E O Long; D N Burshtyn; W P Clark; M Peruzzi; S Rajagopalan; S Rojo; N Wagtmann; C C Winter
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

Review 5.  Natural killer cells: from no receptors to too many.

Authors:  L L Lanier
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

6.  Ly49A allelic variation and MHC class I specificity.

Authors:  I K Mehta; J Wang; J Roland; D H Margulies; W M Yokoyama
Journal:  Immunogenetics       Date:  2001-09       Impact factor: 2.846

Review 7.  Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors.

Authors:  M Colonna
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

8.  Inducible expression of the gp49B inhibitory receptor on NK cells.

Authors:  L L Wang; D T Chu; A O Dokun; W M Yokoyama
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

9.  Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules.

Authors:  J C Ryan; J Turck; E C Niemi; W M Yokoyama; W E Seaman
Journal:  J Immunol       Date:  1992-09-01       Impact factor: 5.422

10.  The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand.

Authors:  N Matsumoto; M Mitsuki; K Tajima; W M Yokoyama; K Yamamoto
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

View more
  28 in total

1.  Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells.

Authors:  Céline Eidenschenk; Karine Crozat; Philippe Krebs; Ramon Arens; Daniel Popkin; Carrie N Arnold; Amanda L Blasius; Chris A Benedict; Eva Marie Y Moresco; Yu Xia; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.

Authors:  Kutlu G Elpek; Mark P Rubinstein; Angelique Bellemare-Pelletier; Ananda W Goldrath; Shannon J Turley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 3.  Extrinsic and intrinsic regulation of early natural killer cell development.

Authors:  Markus D Boos; Kevin Ramirez; Barbara L Kee
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  Distinct mechanisms of tumor resistance to NK killing: of mice and men.

Authors:  Drew M Pardoll
Journal:  Immunity       Date:  2015-04-21       Impact factor: 31.745

Review 5.  Resisting viral infection: the gene by gene approach.

Authors:  Eva Marie Y Moresco; Bruce Beutler
Journal:  Curr Opin Virol       Date:  2011-11-06       Impact factor: 7.090

Review 6.  Principles of immunology and its nuances in the central nervous system.

Authors:  Gavin P Dunn; Hideho Okada
Journal:  Neuro Oncol       Date:  2015-11       Impact factor: 12.300

7.  Protective and pathologic roles of the immune response to mouse hepatitis virus type 1: implications for severe acute respiratory syndrome.

Authors:  Aaruni Khanolkar; Stacey M Hartwig; Brayton A Haag; David K Meyerholz; Lecia L Epping; Jodie S Haring; Steven M Varga; John T Harty
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

8.  Innate immune responses in primary HIV-1 infection.

Authors:  Persephone Borrow; Nina Bhardwaj
Journal:  Curr Opin HIV AIDS       Date:  2008-01       Impact factor: 4.283

9.  Murine natural killer immunoreceptors use distinct proximal signaling complexes to direct cell function.

Authors:  Rebecca M May; Mariko Okumura; Chin-Jung Hsu; Hamid Bassiri; Enjun Yang; Gregory Rak; Emily M Mace; Naomi H Philip; Weiguo Zhang; Tobias Baumgart; Jordan S Orange; Kim E Nichols; Taku Kambayashi
Journal:  Blood       Date:  2013-02-13       Impact factor: 22.113

10.  Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw*0102: a bioinformatic approach to the prediction of new epitopes.

Authors:  Valerie A Walshe; Channa K Hattotuwagama; Irini A Doytchinova; Mailee Wong; Isabel K Macdonald; Arend Mulder; Frans H J Claas; Pierre Pellegrino; Jo Turner; Ian Williams; Emma L Turnbull; Persephone Borrow; Darren R Flower
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.